- Home
- CVRX vs TARA Comparison
CVRX vs TARA Comparison
Compare CVRX & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVRX
- TARA
- Stock Information
- Founded
- CVRX 2000
- TARA N/A
- Country
- CVRX United States
- TARA United States
- Employees
- CVRX N/A
- TARA N/A
- Industry
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CVRX Health Care
- TARA Health Care
- Exchange
- CVRX Nasdaq
- TARA Nasdaq
- Market Cap
- CVRX 203.9M
- TARA 196.8M
- IPO Year
- CVRX 2021
- TARA N/A
- Fundamental
- Price
- CVRX $10.68
- TARA $5.16
- Analyst Decision
- CVRX Buy
- TARA Strong Buy
- Analyst Count
- CVRX 7
- TARA 6
- Target Price
- CVRX $14.00
- TARA $19.80
- AVG Volume (30 Days)
- CVRX 195.1K
- TARA 513.1K
- Earning Date
- CVRX 11-05-2025
- TARA 11-03-2025
- Dividend Yield
- CVRX N/A
- TARA N/A
- EPS Growth
- CVRX N/A
- TARA N/A
- EPS
- CVRX N/A
- TARA N/A
- Revenue
- CVRX $54,652,000.00
- TARA N/A
- Revenue This Year
- CVRX $11.32
- TARA N/A
- Revenue Next Year
- CVRX $18.58
- TARA N/A
- P/E Ratio
- CVRX N/A
- TARA N/A
- Revenue Growth
- CVRX 23.11
- TARA N/A
- 52 Week Low
- CVRX $4.30
- TARA $2.21
- 52 Week High
- CVRX $18.55
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- CVRX 69.71
- TARA 56.62
- Support Level
- CVRX $9.71
- TARA $4.96
- Resistance Level
- CVRX $11.11
- TARA $5.39
- Average True Range (ATR)
- CVRX 0.54
- TARA 0.27
- MACD
- CVRX 0.05
- TARA -0.10
- Stochastic Oscillator
- CVRX 76.63
- TARA 15.35
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).